Stock Earnings

Question 1

What are Canntab Therapeutics Limited's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Stonepath Group Inc has a total asset of $135, Net loss of $-9

Question 2

What are the key financial ratios for CTABF?

Accepted Answer

Stonepath Group Inc's Current ratio is 1.4, has a Net margin is -2.19, sales per share of $9.4.

Question 3

How is Canntab Therapeutics Limited's revenue broken down by segment or geography?

Accepted Answer

Stonepath Group Inc largest revenue segment is Retail, at a revenue of 1,816,241,000,000 in the most earnings release.For geography, Chile is the primary market for Stonepath Group Inc, at a revenue of 2,997,276,000,000.

Question 4

Is Canntab Therapeutics Limited profitable?

Accepted Answer

no, according to the latest financial statements, Stonepath Group Inc has a net loss of $-9

Question 5

Does Canntab Therapeutics Limited have any liabilities?

Accepted Answer

yes, Stonepath Group Inc has liability of 96

Question 6

How many outstanding shares for Canntab Therapeutics Limited?

Accepted Answer

Stonepath Group Inc has a total outstanding shares of 43.74

Breakdown	TTM	12/31/2005	12/31/2004	12/31/2003	12/31/2002	12/31/2001
Revenue	396	410	367	220	122	15
Revenue Growth (YoY)	21%	12%	67%	80%	713%	--
Cost of Revenue	322	323	282	158	86	10
Gross Profit	74	86	84	61	36	5
Selling, General & Admin	78	82	81	56	33	9
Research & Development	--	--	--	--	--	--
Operating Expenses	83	87	85	59	35	10
Other Non Operating Income (Expenses)	6	0	-3	-1	0	0
Pretax Income	-28	-6	-9	0	0	-3
Income Tax Expense	0	1	2	0	0	0
Net Income	-29	-9	-13	0	15	-21
Net Income Growth	93%	-31%	--	-100%	-171%	-74%
Shares Outstanding (Diluted)	43.77	43.59	38.97	29.62	29.23	20.51
Shares Change (YoY)	0%	12%	32%	1%	43%	16%
EPS (Diluted)	-0.65	-0.22	-0.33	-0.01	0.52	-1.05
EPS Growth	92%	-33%	1,798%	-103%	-150%	-77%
Free Cash Flow	-1	3	-6	-8	-2	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	18.68%	20.97%	22.88%	27.72%	29.5%	33.33%
Operating Margin	-2.27%	0%	-0.27%	0.9%	0%	-26.66%
Profit Margin	-7.32%	-2.19%	-3.54%	0%	12.29%	-140%
Free Cash Flow Margin	-0.25%	0.73%	-1.63%	-3.63%	-1.63%	0%
EBITDA	-6	4	3	4	2	-4
EBITDA Margin	-1.51%	0.97%	0.81%	1.81%	1.63%	-26.66%
D&A For EBITDA	3	4	4	2	2	0
EBIT	-9	0	-1	2	0	-4
EBIT Margin	-2.27%	0%	-0.27%	0.9%	0%	-26.66%
Effective Tax Rate	0%	-16.66%	-22.22%	0%	0%	0%

Canntab Therapeutics Limited (CTABF) Financial

CTABF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

CTABF Income

Follow-Up Questions